Reference
Kim YJ, et al. Factors associated with ocular adverse event after immune checkpoint inhibitor treatment. Cancer Immunology Immunotherapy 69: 2441-2452, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1007/s00262-020-02635-3
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1838, 60 (2021). https://doi.org/10.1007/s40278-021-89379-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-89379-2